Contact Information
222 Phillip Stone Way , Central City, Kentucky 42330, United States
Detailed Information
A New Start II LLC
-
Services:
- This facility administers/prescribes medication for alcohol use disorder
- Regular outpatient treatment
- Outpatient detoxification
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Alcohol Detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- State Substance use treatment agency
- Buprenorphine detoxification
- Relapse prevention with naltrexone
- Prescribes naltrexone
- Buprenorphine maintenance
- Maintenance service with medically supervised withdrawal after stabilization
- Lofexidine or Clonidine detoxification
- Prescribes buprenorphine
- Naloxone and overdose education
- Outcome follow-up after discharge
- Opioid use disorder clients only
- Male
- Female
- Self-help groups
- Mentoring/peer support
- Housing services
- Employment counseling or training
- Recovery coach
- Assistance with obtaining social services
- Case management service
- Mental health services
- Adults
- Young Adults
- Sign language services for the deaf and hard of hearing
- Substance use disorder education
- Family counseling
- Marital/couples counseling
- Group counseling
- Individual counseling
- HIV testing
- Testing for Hepatitis B (HBV)
- STD testing
- Testing for Hepatitis C (HCV)
- Drug or alcohol urine screening
- Cognitive behavioral therapy
- Anger management
- Trauma-related counseling
- Telemedicine/telehealth therapy
- Brief intervention
- Matrix Model
- 12-step facilitation
- Substance use disorder counseling
- Contingency management/motivational incentives
- Motivational interviewing
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Private health insurance
- State-financed health insurance plan other than Medicaid
- Cash or self-payment
- Medicaid
- Medicare
- Federal military insurance (e.g., TRICARE)
- Smoking permitted in designated area
- Buprenorphine sub-dermal implant
- Clonidine
- Medication for mental disorders
- Buprenorphine with naloxone
- Naltrexone (oral)
- Buprenorphine (extended-release, injectable)
- Acamprosate (Campral®)
- Buprenorphine without naloxone
- Lofexidine
- Vaping permitted in designated area
- Comprehensive mental health assessment
- Professional interventionist/educational consultant
- Screening for substance use
- Screening for tobacco use
- Comprehensive substance use assessment
- Screening for mental disorders
- Interim services for clients
- Complete medical history/physical exam
- Outreach to persons in the community
- Substance use treatment
- Detoxification
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- In-network prescribing entity
- Private for-profit organization
Type of Alcohol Use Disorder Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Detoxification (medical withdrawal) Services
License/Certification/Accreditation
Type of Opioid Treatment
Transitional Services
Exclusive Services
Gender Accepted
Recovery Support Services
Ancillary Services
Age Groups Accepted
Language Services
Education and Counseling Services
Testing
Treatment Approaches
Opioid Medications used in Treatment
Payment/Insurance/Funding Accepted
Facility Smoking Policy
Pharmacotherapies
Facility Vaping Policy
Assessment/Pre-treatment
Type of Care
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Operation (e.g., Private, Public)
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm